Role of OX34 in treatment of acute rejection after small bowel transplantation in rats

JI Gang,LIN Yan,WANG Wei-Zhong,GUAN Wen-Xian,NIU Wei-Bo
DOI: https://doi.org/10.3321/j.issn:1000-2790.2006.02.006
2006-01-01
Abstract:AIM: To investigate the therapeutic effect of OX34 against acute rejection after small bowel transplantation(SBT) in rats.METHODS: A total of 72 rats of 2 inbred lines(SD and Wistar) were randomly divided into 4 groups(A,B,C and D).Group A(n18) accepted fictitious operation and was fed with common forage;Group B(n18) underwent iso-strain SBT and the treatment of post-operation such as routine fluid replacement and antibiotic administration;Group C(n18) had aniso-strain SBT and the same post-operative treatment as group B;and Group D(n18)got the same operation as group C and OX34 was added into the same post-operative treatment as group B.Samples of grafts and peripheral blood were taken from 3,5 and 7 d after SBT and were detected by pathology and flow cytometer.(RESULTS:) The survival time and the positive expression rate of CD2 in peripheral blood of group C were significantly different compared with those of the other 3 groups(P<0.05).Acute(rejection) developed from mild to severe when the samples were taken form 3,5,7 d after SBT.Part of the grafts from group D suffered from a mild degree of acute rejection 5 and 7 d after SBT,while none of the group A and B showed pathological evidence of acute rejection.CONCLUSION: OX34 significantly suppresses the acute rejection after SBT in vivo.
What problem does this paper attempt to address?